DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm Market Forecast
Some of the key facts of the Abdominal Aortic Aneurysm Market Report:
- The Abdominal Aortic Aneurysm market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
- According to a 2019 study by Palma M. Shaw et al., abdominal aortic aneurysms are more common after age 60 and peak in the seventh and eighth decades of life
- According to Anna Hohnecket al.’s 2019 study, 40 out of 566 patients (7.1%) had detectable AAAs. AAA was initially diagnosed in 2.5% of patients, whereas the remaining 26 patients (2.1% of patients) had either received prior treatment or had already received a diagnosis
- A number companies are also creating medical devices for the treatment of Abdominal Aortic Aneurysm, including Boston Scientific Corporation (TriVascular Stent-Graft System), Bolton Medical (Treovance stent-graft), Cordis Corporation (Cordis AAA stent graft system), and TriVascular (TriVascular Ovation Abdominal Stent Graft System).
- In the United States, 200,000 persons are diagnosed with an abdominal aortic aneurysm (AAA) annually
- Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, and others
- Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, Telmisartan, CRD007, and others
- The Abdominal Aortic Aneurysm epidemiology based on gender analyzed that Abdominal aortic aneurysms are more common in men
- The Abdominal Aortic Aneurysm market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics.
Abdominal Aortic Aneurysm Overview
An abdominal aortic aneurysm (AAA) is a localized swelling of the aorta in the abdomen that is more than 50% larger than normal or has a diameter of more than 3 cm. It happens when the walls of the abdominal aorta weaken and protrude outward like a balloon due to atherosclerosis or plaque accumulation.
Get a Free sample for the Abdominal Aortic Aneurysm Market Report
https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market
Abdominal Aortic Aneurysm Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Abdominal Aortic Aneurysm Epidemiology Segmentation:
The Abdominal Aortic Aneurysm market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Total Prevalence of Abdominal Aortic Aneurysm
- Prevalent Cases of Abdominal Aortic Aneurysm by severity
- Gender-specific Prevalence of Abdominal Aortic Aneurysm
- Diagnosed Cases of Episodic and Chronic Abdominal Aortic Aneurysm
Download the report to understand which factors are driving Abdominal Aortic Aneurysm epidemiology trends @ Abdominal Aortic Aneurysm Epidemiology Forecast
Abdominal Aortic Aneurysm Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Abdominal Aortic Aneurysm Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Abdominal Aortic Aneurysm Therapies and Key Companies
- Metformin Glucophage: Merck Serono
- Ticagrelor: AstraZeneca
- Telmisartan: Medtronic
- CRD007: RSPR Pharma AB
Discover more about therapies set to grab major Abdominal Aortic Aneurysm market share @ Abdominal Aortic Aneurysm Treatment Market
Scope of the Abdominal Aortic Aneurysm Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, and others
- Key Abdominal Aortic Aneurysm Therapies: Metformin Glucophage, Ticagrelor, Telmisartan, CRD007, and others
- Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
- Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Abdominal Aortic Aneurysm Unmet Needs, KOL’s views, Analyst’s views, Abdominal Aortic Aneurysm Market Access and Reimbursement
To know more about Abdominal Aortic Aneurysm companies working in the treatment market, visit @ Abdominal Aortic Aneurysm Clinical Trials and Therapeutic Assessment
Table of Contents
1. Abdominal Aortic Aneurysm Market Report Introduction
2. Executive Summary for Abdominal Aortic Aneurysm
3. SWOT analysis of Abdominal Aortic Aneurysm
4. Abdominal Aortic Aneurysm Patient Share (%) Overview at a Glance
5. Abdominal Aortic Aneurysm Market Overview at a Glance
6. Abdominal Aortic Aneurysm Disease Background and Overview
7. Abdominal Aortic Aneurysm Epidemiology and Patient Population
8. Country-Specific Patient Population of Abdominal Aortic Aneurysm
9. Abdominal Aortic Aneurysm Current Treatment and Medical Practices
10. Abdominal Aortic Aneurysm Unmet Needs
11. Abdominal Aortic Aneurysm Emerging Therapies
12. Abdominal Aortic Aneurysm Market Outlook
13. Country-Wise Abdominal Aortic Aneurysm Market Analysis (2019–2032)
14. Abdominal Aortic Aneurysm Market Access and Reimbursement of Therapies
15. Abdominal Aortic Aneurysm Market Drivers
16. Abdominal Aortic Aneurysm Market Barriers
17. Abdominal Aortic Aneurysm Appendix
18. Abdominal Aortic Aneurysm Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services